What is it about?
Extracorporeal membrane oxygenation (ECMO) provides support to the heart and lungs when all other treatments have failed. Whilst ECMO offers an increased chance of survival to critically ill patients, it is associated with a high risk of infection. We aim to perform a study which determines the prevalence of hospital-acquired infection in neonatal, paediatric and adult patients receiving ECMO across Australia and New Zealand, because we currently do not know this. By doing so, we hope to develop interventions to reduce the burden of infection on patients receiving ECMO.
Featured Image
Read the Original
This page is a summary of: Nosocomial infection prevalence in patients undergoing extracorporeal membrane oxygenation (ECMO): protocol for a point prevalence study across Australia and New Zealand, BMJ Open, July 2019, BMJ,
DOI: 10.1136/bmjopen-2019-029293.
You can read the full text:
Contributors
The following have contributed to this page







